FDA Inspection 731947 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3000204268

The FDA completed an inspection of Oklahoma Blood Institute on Jun 28, 2011 in Ponca City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 28, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ponca City, OK (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.